Table 1.
Diagnostic criteria of persistent inflammatory sero-negative COVIDa
| A patient is defined as having persistent inflammatory sero-negative COVID if they fulfil the following criteria and no alternative diagnosis: | |
|---|---|
| 1. Host criterion | B-cell depleting disease or therapy, including the following:
|
| 2. Clinical criterion | Prolonged or remitting fever (total >7 d) with elevated CRP levels plus either one of the following: prostration, non-resolving cough and dyspnea (total >14 d), abnormal chest imaging showing pneumonitis (bilateral ground glass opacities). |
| 3. Virological criterion, defined as either of the following | |
B-cell maturation antigen (BCMA), CD, cluster of differentiation; COVID, coronavirus disease; CRP, C-reactive protein; Real-time PCR (RT-PCR); SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Being sero-negative before and at the time of the onset of acute infection (regardless and despite vaccination) is a characteristic of this entity. It was not comprehensively included in the criteria for diagnosis because of practical reasons; the diagnosis can be made without a specialized blood test.
A positive SARS-CoV-2 result from either a nasopharyngeal swab or lower-respiratory specimen demonstrating the same variant using sequencing supports the diagnosis but is not mandatory.
Undetectable levels or low titres according to a local serology platform; patients who were treated with monoclonal antibodies for prevention may have higher titres.